Purinergic neurone-glia signalling in cognitive-related pathologies

Neuropharmacology. 2016 May:104:62-75. doi: 10.1016/j.neuropharm.2015.08.005. Epub 2015 Aug 6.

Abstract

Neuroglia, represented by astrocytes, oligodendrocytes, NG glia and microglia are homeostatic, myelinating and defensive cells of the brain. Neuroglial cells express various combinations of purinoceptors, which contribute to multiple intercellular signalling pathways in the healthy and diseased nervous system. Neurological diseases are invariably associated with profound neuroglial remodelling, which is manifest by reactive gliosis, pathological remodelling and functional atrophy of various types of glial cells. Gliopathology is disease and region specific and produces multiple glial phenotypes that may be neuroprotective or neurotoxic. In this review we summarise recent knowledge on the role of glial purinergic signalling in cognitive-related neurological diseases. This article is part of the Special Issue entitled 'Purines in Neurodegeneration and Neuroregeneration'.

Keywords: Astrocyte; Cognition; Dementia; Microglia; Neurodegeneration; Neuropsychiatric diseases; Oligodendrocyte; Purinergic signalling; Purinoceptors.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Brain / metabolism*
  • Cognition Disorders / metabolism*
  • Humans
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / psychology
  • Neuroglia / metabolism*
  • Neurons / metabolism*
  • Receptors, Purinergic P2X / metabolism*
  • Receptors, Purinergic P2Y / metabolism*
  • Signal Transduction

Substances

  • Receptors, Purinergic P2X
  • Receptors, Purinergic P2Y
  • Adenosine Triphosphate